128 related articles for article (PubMed ID: 8200988)
21. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.
Vossen AC; Tibbe GJ; Kroos MJ; van de Winkel JG; Benner R; Savelkoul HF
Eur J Immunol; 1995 Jun; 25(6):1492-6. PubMed ID: 7614975
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Meijer RT; Surachno S; Yong SL; Bemelman FJ; Florquin S; Ten Berge IJ; Schellekens PT
Clin Exp Immunol; 2003 Sep; 133(3):485-92. PubMed ID: 12930378
[TBL] [Abstract][Full Text] [Related]
23. Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone.
Alegre ML; Vandenabeele P; Depierreux M; Florquin S; Deschodt-Lanckman M; Flamand V; Moser M; Leo O; Urbain J; Fiers W
J Immunol; 1991 Feb; 146(4):1184-91. PubMed ID: 1825107
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
[TBL] [Abstract][Full Text] [Related]
25. Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.
Lv M; Li Y; Yu M; Sun Y; Lin Z; Qiao C; Luo Q; Gu X; Huang Y; Feng J; Shen B
Int J Biochem Cell Biol; 2007; 39(6):1142-55. PubMed ID: 17446118
[TBL] [Abstract][Full Text] [Related]
26. Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
Richards J; Auger J; Peace D; Gale D; Michel J; Koons A; Haverty T; Zivin R; Jolliffe L; Bluestone JA
Cancer Res; 1999 May; 59(9):2096-101. PubMed ID: 10232594
[TBL] [Abstract][Full Text] [Related]
27. Partial TCR signals delivered by FcR-nonbinding anti-CD3 monoclonal antibodies differentially regulate individual Th subsets.
Smith JA; Tang Q; Bluestone JA
J Immunol; 1998 May; 160(10):4841-9. PubMed ID: 9590231
[TBL] [Abstract][Full Text] [Related]
28. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
J Immunol; 1993 Jun; 150(11):5163-74. PubMed ID: 7684422
[TBL] [Abstract][Full Text] [Related]
29. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
30. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
Zhu BQ; Ju SW; Shu YQ
Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
[TBL] [Abstract][Full Text] [Related]
31. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
[TBL] [Abstract][Full Text] [Related]
32. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.
Zhou Z; Kim YJ; Pollok K; Hurtado J; Lee JK; Broxmeyer HE; Kwon BS
J Immunol; 1993 Oct; 151(8):4333-41. PubMed ID: 8409405
[TBL] [Abstract][Full Text] [Related]
33. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
34. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
[TBL] [Abstract][Full Text] [Related]
35. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
36. T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.
Brown SA; Lucas BA; Waid TH; McKeown JW; Barve S; Jackson LR; Thompson JS
Clin Transplant; 1996 Dec; 10(6 Pt 2):607-13. PubMed ID: 8996751
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.
Andersson UG; Björk L; Skansén-Saphir U; Andersson JP
Immunology; 1993 Jun; 79(2):211-6. PubMed ID: 8344700
[TBL] [Abstract][Full Text] [Related]
38. Humoral immunodeficiency in patients after bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Mauz-Körholz C; Zintl F; Burdach S
Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382
[TBL] [Abstract][Full Text] [Related]
39. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
40. Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.
Meijer RT; Yong SL; ten Berge IJ; van Lier RA; Schellekens PT
Clin Exp Immunol; 2001 Mar; 123(3):511-9. PubMed ID: 11298141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
